Georgetown University researchers estimate that anthracycline-based chemotherapy for breast cancer may reduce survivors' non‑cancer life expectancy by roughly 9.4 years, according to population‑level modeling. 🔗 Read the full story on GazeWire #Health #Biotech #Crispr #GazeWire
Private to this visit. Text and context are processed by AI.